Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures subdued as investors weigh earnings, oil prices
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil prices hit fresh 6-week highs on renewed Middle East tensions
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Evoke Pharma (EVOK) Reports Q2 Loss of $0.93/sh
August 13, 2024 8:15 AM EDTEvoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.93), versus ($6.71) reported last year. Revenue for the quarter came in at $2.55 million, versus $1.13 million reported last year.
Based on net sales generated in the first two quarters of 2024, Evoke is revising its 2024 guidance... More